Notably, the overexpression of ZNF500 has been shown to inhibit breast cancer cell proliferation both in vivo and in vitro by activating the P53-P21-E2F4 signal transduction axis and directly interacting with p53 via its C2H2 domain [84]. Here, TP53 is linked to breast carcinoma.